SCHEMBL4861895

SCHEMBL4861895

CCC#CCOc1nsc(N2CCCC(C)C2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.35
ALDH1A1 P00352 4/20 0.35
TSHR P16473 3/20 0.35
KDM4E B2RXH2 3/20 0.35
HSD17B10 Q99714 3/20 0.35
NPC1 O15118 2/20 0.35
HPGD P15428 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.33
MAP4K4 O95819 1/20 0.32
TLR7 Q9NYK1 1/20 0.31
JAK3 P52333 1/20 0.31
KMT2A Q03164 3/20 0.30
MEN1 O00255 2/20 0.30
GAA P10253 2/20 0.30
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4858714 0.89 ALDH1A1 (0.36) L3MBTL1ALDH1A1TSHRKDM4EHSD17B10
SCHEMBL4860317 0.85 ALDH1A1 (0.42) L3MBTL1ALDH1A1TSHRKDM4ENPC1
SCHEMBL4857171 0.85
SCHEMBL4854852 0.85 MEN1 (0.36) L3MBTL1ALDH1A1TSHRKDM4ENPC1
SCHEMBL4858844 0.84 MEN1 (0.38) L3MBTL1ALDH1A1TSHRKDM4ENPC1
SCHEMBL4859622 0.84 MEN1 (0.38) L3MBTL1ALDH1A1TSHRKDM4ENPC1
SCHEMBL4859254 0.80 KDM4E (0.32) ALDH1A1TSHRKDM4EHPGDSMN1; SMN2
SCHEMBL4859561 0.78 ALDH1A1 (0.39) L3MBTL1ALDH1A1TSHRKDM4EHPGD
SCHEMBL4849230 0.77 SMN1; SMN2 (0.40) ALDH1A1KDM4EHSD17B10NPC1HPGD
SCHEMBL4857870 0.74 ALDH1A1 (0.40) L3MBTL1ALDH1A1TSHRKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2492265-A1 1,2,4-Thiadiazole Compounds and Pests Controlling Composition Containing the same Sumitomo Chemical Company, Limited (JP) 2012-08-29 EP disclosed
US-7371746-B2 1,2,4-Thiadiazole compounds and pests controlling composition containing the same SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-05-13 US disclosed
US-7371746-B2 1,2,4-Thiadiazole compounds and pests controlling composition containing the same SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-05-13 US disclosed
EP-1765798-A2 1,2,4- THIADIAZOLE COMPOUNDS AND PESTS CONTROLLING COMPOSITION CONTAINING THE SAME Sumitomo Chemical Company, Limited (JP) 2007-03-28 EP disclosed
US-20070004722-A1 1,2,4-Thiadazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-01-04 US disclosed
US-20070004722-A1 1,2,4-Thiadazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-01-04 US disclosed
WO-2005037805-A2 1,2,4-THIADIAZOLE COMPOUNDS AND PESTS CONTROLLING COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004722-A1 1,2,4-Thiadazole compounds and use thereof CYP4F3, CYP4B1, CYP4X1 L3MBTL1 203/4885ALDH1A1 248/4885TSHR 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.